Authors:
MONNET I
BRIENZA S
HUGRET F
VOISIN S
GASTIABURU J
SALTIEL JC
SOULIE P
ARMAND JP
CVITKOVIC E
DECREMOUX H
Citation: I. Monnet et al., PHASE-II STUDY OF OXALIPLATIN IN POOR-PROGNOSIS NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 34(7), 1998, pp. 1124-1127
Authors:
DECREMOUX H
BEKRADDA M
MONNET I
SOULIE P
SALTIEL S
MISSET JL
FANDI A
BENSMAINE MA
CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 474-474
Authors:
DECREMOUX H
BEKRADDA M
MONNET I
SOULIE P
SALTIEL S
MISSET JL
FANDI A
BENSMAINE MA
CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 446-446
Authors:
BEAUD C
FUHRMAN C
PERCHET H
MONNET I
CHOUAID C
HOUSSET B
Citation: C. Beaud et al., THIAMINE-DEFICIENCY - A CAUSE OF HEART-FA ILURE NOT TO BE MISDIAGNOSED, Revue des maladies respiratoires, 15(3), 1998, pp. 303-304
Authors:
CHOUAID C
BASSINET L
FUHRMAN C
MONNET I
HOUSSET B
Citation: C. Chouaid et al., ROUTINE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IS NOT COST-EFFECTIVE AND DOES NOT INCREASE PATIENT COMFORT IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - AN ANALYSIS USING A MARKOV MODEL, Journal of clinical oncology, 16(8), 1998, pp. 2700-2707
Authors:
LAPLANCHE A
MONNET I
SANTOSMIRANDA JA
BARDET E
LEPECHOUX C
TARAYRE M
ARRIAGADA R
Citation: A. Laplanche et al., CONTROLLED CLINICAL-TRIAL OF PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION, Lung cancer, 21(3), 1998, pp. 193-201
Authors:
BUARD A
VIVO C
MONNET I
BOUTIN C
PILATTE Y
JAURAND MC
Citation: A. Buard et al., HUMAN-MALIGNANT MESOTHELIOMA CELL-GROWTH - ACTIVATION OF JANUS KINASE-2 AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1-ALPHA FOR INHIBITION BY INTERFERON-GAMMA, Cancer research, 58(4), 1998, pp. 840-847
Authors:
PHANBICH L
BUARD A
PETIT JF
ZENG L
TENU JP
CHRETIEN P
MONNET I
BOUTIN C
BIGNON J
LEMAIRE G
JAURAND MC
Citation: L. Phanbich et al., DIFFERENTIAL RESPONSIVENESS OF HUMAN AND RAT MESOTHELIOMA CELL-LINES TO RECOMBINANT INTERFERON-GAMMA, American journal of respiratory cell and molecular biology, 16(2), 1997, pp. 178-186
Authors:
CIULEANU TE
CHAHINE A
TODOR N
MONNET I
AZLI N
VOISIN S
RIGGI M
SALTIEL JC
ARMAND JP
RUFFIE P
DECREMOUX H
CVITKOVIC E
Citation: Te. Ciuleanu et al., NEOADJUVANT CISPLATIN-VINDESINE VINORELBINE BASED COMBINATION CHEMOTHERAPY (CT) FOR STAGE-III NONSMALL CELL LUNG-CANCER (NSCLC)/, European journal of cancer, 33, 1997, pp. 1056-1056
Authors:
TRANDAFIR L
RUFFIE P
BOREL C
MONNET I
SOULIE P
ADAMS D
CVITKOVIC E
ARMAND JP
Citation: L. Trandafir et al., HIGHER DOSES OF ALPHA-INTERFERON DO NOT INCREASE THE ACTIVITY OF THE WEEKLY CISPLATIN-INTERFERON COMBINATION IN ADVANCED MALIGNANT MESOTHELIOMA, European journal of cancer, 33(11), 1997, pp. 1900-1902
Authors:
CHARIOT P
DUBREUILLEMAIRE ML
ZHOU JY
LAMIA B
DUME L
LARCHER B
MONNET I
LEVY Y
ASTIER A
GHERARDI R
Citation: P. Chariot et al., MUSCLE INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS IS ASSOCIATED WITH MARKED SELENIUM DEFICIENCY, Muscle & nerve, 20(3), 1997, pp. 386-389
Authors:
SOULIE P
RUFFIE P
TRANDAFIR L
MONNET I
TARDIVON A
TERRIER P
CVITKOVIC E
LECHEVALIER T
ARMAND JP
Citation: P. Soulie et al., COMBINED SYSTEMIC CHEMOIMMUNOTHERAPY IN ADVANCED DIFFUSE MALIGNANT MESOTHELIOMA - REPORT OF A PHASE I-II STUDY OF WEEKLY CISPLATIN INTERFERON ALFA-2A, Journal of clinical oncology, 14(3), 1996, pp. 878-885
Authors:
ARRIAGADA R
LECHEVALIER T
BORIE F
RIVIERE A
CHOMY P
MONNET I
TARDIVON A
VIADER F
TARAYRE M
BENHAMOU S
Citation: R. Arriagada et al., PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER IN COMPLETE REMISSION, Journal of the National Cancer Institute, 87(3), 1995, pp. 183-190
Authors:
ARRIAGADA R
MONNET I
RIVIERE A
SANTOSMIRANDA JA
BARDET E
LAPLANCHE A
Citation: R. Arriagada et al., PROPHYLACTIC CRANIAL IRRADIATION (PCI) FOR PATIENTS (PTS) WITH SMALL-CELL LUNG-CANCER (SCLC) IN COMPLETE REMISSION (CR), European journal of cancer, 31A, 1995, pp. 83-83
Authors:
FLEURYFEITH J
KHEUANG L
ZENG L
BIGNON J
BOUTIN C
MONNET I
JAURAND MC
Citation: J. Fleuryfeith et al., HUMAN-MALIGNANT MESOTHELIAL CELLS - VARIABILITY OF ULTRASTRUCTURAL FEATURES IN ESTABLISHED AND NUDE-MICE TRANSPLANTED CELL-LINES, Journal of pathology, 177(2), 1995, pp. 209-215
Authors:
AISNER J
BOUTIN C
BUTCHART EG
CHAHINIAN P
FABER LP
HEELAN R
MATTSON K
PASS HI
PATZ EF
ROBINSON B
RUSCH VW
TAMMILEHTO L
VOGELZANG NJ
AISNER S
ANTMAN KH
BELANI CP
BIGNON J
BRODIN O
FEINS R
GINSBERG R
HAMMAR S
HERNDON J
HILLARDEL G
ILSON D
KELLER S
KELSEN D
KRASNA M
MAASILTA P
MONNET I
ROGGLI VL
RUFFIE P
SALMINEN U
SALTZ L
STRAUSS G
VIALLAT JR
VONBULTZINGSLOWEN F
Citation: J. Aisner et al., A PROPOSED NEW INTERNATIONAL TNM STAGING SYSTEM FOR MALIGNANT PLEURALMESOTHELIOMA, Chest, 108(4), 1995, pp. 1122-1128
Authors:
PIGNON JP
TARAYRE M
AUQUIER A
ARRIAGADA R
LECHEVALIER T
RUFFIE P
RIVIERE A
MONNET I
CHOMY P
TUCHAIS C
Citation: Jp. Pignon et al., TRIANGULAR TEST AND RANDOMIZED TRIALS - PRACTICAL PROBLEMS IN A SMALLLUNG-CANCER TRIAL, Statistics in medicine, 13(13-14), 1994, pp. 1415-1421
Authors:
ZENG L
FLEURYFEITH J
MONNET I
BOUTIN C
BIGNON J
JAURAND MC
Citation: L. Zeng et al., IMMUNOCYTOCHEMICAL CHARACTERIZATION OF CELL-LINES FROM HUMAN-MALIGNANT MESOTHELIOMA - CHARACTERIZATION OF HUMAN MESOTHELIOMA CELL-LINES BY IMMUNOCYTOCHEMISTRY WITH A PANEL OF MONOCLONAL-ANTIBODIES, Human pathology, 25(3), 1994, pp. 227-234
Authors:
MONTI G
JAURAND MC
MONNET I
CHRETIEN P
SAINTETIENNE L
ZENG L
PORTIER A
DEVILLIER P
GALANAUD P
BIGNON J
EMILIE D
Citation: G. Monti et al., INTRAPLEURAL PRODUCTION OF INTERLEUKIN-6 DURING MESOTHELIOMA AND ITS MODULATION BY GAMMA-INTERFERON TREATMENT, Cancer research, 54(16), 1994, pp. 4419-4423
Authors:
BOUTIN C
NUSSBAUM E
MONNET I
BIGNON J
VANDERSCHUEREN R
GUERIN JC
MENARD O
MIGNOT P
DABOUIS G
DOUILLARD JY
Citation: C. Boutin et al., INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 74(9), 1994, pp. 2460-2467
Authors:
BOUTIN C
NUSSBAUM E
MONNET I
BIGNON J
VANDERSCHUEREN R
GUERIN JC
MENARD O
MIGNOT P
DABOUIS G
DOUILLARD JY
Citation: C. Boutin et al., INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 74(9), 1994, pp. 2460-2467
Authors:
CHARIOT P
MONNET I
MOUCHET M
ROHR M
LEFAUCHEUR JP
DUBREUILLEMAIRE ML
CHOUSTERMAN M
GHERARDI R
Citation: P. Chariot et al., DETERMINATION OF THE BLOOD LACTATE-PYRUVATE RATIO AS A NONINVASIVE TEST FOR THE DIAGNOSIS OF ZIDOVUDINE MYOPATHY, Arthritis and rheumatism, 37(4), 1994, pp. 583-586
Authors:
MACCHIARINI P
CHAPELIER AR
MONNET I
VANNETZEL JM
REBISCHUNG JL
CERRINA J
PARQUIN F
LADURIE FL
LENOT B
DARTEVELLE PG
Citation: P. Macchiarini et al., EXTENDED OPERATIONS AFTER INDUCTION THERAPY FOR STAGE IIIB (T4) NONSMALL CELL LUNG-CANCER, The Annals of thoracic surgery, 57(4), 1994, pp. 966-973
Authors:
RIGGI M
CVITKOVIC E
DECREMOUX H
RUFFIE P
MONNET I
VOISIN S
VILLALOBOS W
AZLI N
SALTIEL JC
Citation: M. Riggi et al., CISPLATIN AND CONTINUOUS-INFUSION VINDESINE AND 5-FLUOROURACIL IN NON-SMALL-CELL LUNG-CANCER (NSCLC) (ATTIT-002), European journal of cancer, 29A(13), 1993, pp. 1914-1915
Citation: P. Chariot et al., CYTOCHROME-C-OXIDASE REACTION IMPROVES HISTOPATHOLOGICAL ASSESSMENT OF ZIDOVUDINE MYOPATHY, Annals of neurology, 34(4), 1993, pp. 561-565